124
Participants
Start Date
February 1, 2020
Primary Completion Date
December 1, 2024
Study Completion Date
December 1, 2024
PRESERFLO Microshunt implantation
The intervention consists of the microshunt implantation augmented with mitomycin C application.
Trabeculectomy
The usual care / control group will undergo a standard fornix based trabeculectomy augmented with mitomycin C application.
Maastricht University Medical Center+ (MUMC+), Maastricht
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Maastricht University Medical Center
OTHER